SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,787.83 23.60
( 0.03%)

Global Indices

Nasdaq

52,403.42 -403.65
(-0.76%)

Dow Jones

7,657.83 -36.69
(-0.48%)

Hang Seng

65,056.24 -86.54
(-0.13%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.74 0.23
(0.24%)

EUR-INR

110.11 0.28
(0.26%)

GBP-INR

128.27 0.39
(0.30%)

JPY-INR

0.62 0.01
(0.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

-18.1148384

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

52.24

EPS(TTM)

Face Value()

Div & Yield %

Back

Sundaram Finance consolidated net profit rises 33.88% in the June 2026 quarter

Aug 03,2026

Net profit of Sundaram Finance rose 33.88% to Rs 636.19 crore in the quarter ended June 2026 as against Rs 475.21 crore during the previous quarter ended June 2025. Sales rose 12.57% to Rs 2644.13 crore in the quarter ended June 2026 as against Rs 2348.93 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2644.13	2348.93	13
OPM %	78.06	76.21	-
PBDT	826.73	631.19	31
PBT	767.19	575.32	33
NP	636.19	475.21	34

74,787.83 23.60 ( 0.03%)

52,403.42 -403.65 (-0.76%)

7,657.83 -36.69 (-0.48%)

65,056.24 -86.54 (-0.13%)

10,664.98 -146.68 (-1.36%)

94.74 0.23 (0.24%)

110.11 0.28 (0.26%)

128.27 0.39 (0.30%)

0.62 0.01 (0.94%)